Mualliflar

  • Xodjiyeva D.T., Qudratov F.O.

##semicolon##

Guillain–Barré sindromi, sitokinlar, antitanalar, immunologik markerlar, gangliozidlar, patogenez, immunokorreksiya.

##submission.citations##

Asbury, A. K., & Cornblath, D. R. (1990). Assessment of current diagnostic criteria for Guillain-Barré syndrome. Annals of Neurology, 27(1), S21–S24.

Bailey, D. M., & Wilkins, R. H. (2018). Guillain-Barré Syndrome: Pathogenesis and Clinical Features. Oxford University Press.

Berger, M. J., & Allen, J. A. (2020). Cytokines in peripheral neuropathies: Diagnostic and therapeutic implications. Journal of Neuroinflammation, 17, 84.

Dalakas, M. C. (2004). Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA, 291(19), 2367–2375.

Doets, A. Y., et al. (2018). Regional variation of Guillain-Barré syndrome. Brain, 141(10), 2866–2877.

Fokke, C., van den Berg, B., Drenthen, J., Walgaard, C., van Doorn, P. A., & Jacobs, B. C. (2014). Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain, 137(1), 33–43.

Griffin, J. W., & Sheikh, K. A. (2005). Neuroimmunology of Guillain–Barré syndrome. Current Opinion in Neurology, 18(5), 527–533.

Hughes, R. A. C., & Cornblath, D. R. (2005). Guillain-Barré syndrome. The Lancet, 366(9497), 1653–1666.

Jacobs, B. C., Rothbarth, P. H., van der Meché, F. G. A., Herbrink, P., Schmitz, P. I. M., de Klerk, M. A., & van Doorn, P. A. (1998). The spectrum of antecedent infections in Guillain–Barré syndrome: a case-control study. Neurology, 51(4), 1110–1115.

Kuwabara, S., & Yuki, N. (2013). Axonal Guillain–Barré syndrome: Concepts and controversies. The Lancet Neurology, 12(12), 1180–1188.

Leonhard, S. E., Mandarakas, M. R., Gondim, F. A. A., et al. (2019). Diagnosis and management of Guillain–Barré syndrome in ten steps. Nature Reviews Neurology, 15, 671–683.

Pritchard, J., Hughes, R. A. C., & Forsyth, R. J. (2021). Intravenous immunoglobulin for Guillain‐Barré syndrome. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD002063.

Rinaldi, S., Brennan, K. M., Kalna, G., et al. (2010). Antibodies to low density lipoprotein receptor–related protein 4 in Guillain–Barré syndrome. Neurology, 74(22), 1807–1812.

Van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B. C., & van Doorn, P. A. (2014). Guillain–Barré syndrome: Pathogenesis, diagnosis, treatment and prognosis. Nature Reviews Neurology, 10(8), 469–482.

Yuki, N., & Hartung, H. P. (2012). Guillain–Barré syndrome. New England Journal of Medicine, 366, 2294–2304.